Long-haul COVID Roundtable

Discussing the impact of long-haul COVID on drug development with key industry experts

Parexel and PharmExec hosted a virtual roundtable of experts to discuss the impact of post-acute sequelae of SARS-CoV-2 (PASC) — otherwise known as Long COVID, post-COVID conditions and/or long-haul COVID – and the challenges faced in research and diagnosis of this complex condition. 

Clare Grace, Chief Patient Officer; Nathalie Sohier, Senior Vice President, Global Head for Infectious Diseases and Vaccines Franchise; Michelle Hoiseth, Chief Data Officer and Fran Oko, Senior Solutions Consultant Director participated with 11 other experts from various stakeholder groups. The roundtable covered the following topics:

 

  • Current research into long COVID
  • Disparate theories of causes
  • Challenges in research and diagnosis
  • Long COVID potential in drug development

 

Please check out the article resulting from the roundtable discussion along with videos spotlighting Parexel’s perspectives based on the discussion:

Download the roundtable article

Uncovering long-term COVID with Parexel and Pharmaceutical Executive (Video Series)

Parexel experts and industry leaders discuss the current research into long-haul COVID and how to design clinical trials to best study therapies for treating it. Parexel's Clare Grace, Chief Patient Officer, moderates this informative discussion. 

PLAYING

Long COVID and Drug Development

PLAYING

Role of DCT

PLAYING

Where is Long COVID Research Going

PLAYING

Role of Regulators

PLAYING

DEI in COVID Research

PLAYING

Collaboration

PLAYING

Data Linking Technology

PLAYING

Flexibility in CT Designs

PLAYING

Splitting vs Lumping

PLAYING

We are always available for a conversation.

*  

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference